September 23, 2015

The Food and Drug Administration on Wednesday announced the approval of Taiho Oncology’s Lonsurf (trifluridine and tipiracil).

September 22, 2015

Keveyis was recently approved for the treatment of primary hyperkalemic and hypokalemic periodic paralysis, a group of rare hereditary disorders that cause episodes of muscle weakness or paralysis. 

September 16, 2015

Care Advantage provides more than 70 therapies and is currently authorized to distribute in all 50 states, districts and territories in the U.S.

September 11, 2015

Repatha is one in a new class of cholesterol medications called PSCK9 (proprotein convertase substilisin kexin type 9) inhibitors, which are potentially an alternative to statins.

September 11, 2015

Mission Pharmacal announced Friday that it would be relaunching its Lithostat (acetohydroxamic acid) kidney stones treatment.

September 10, 2015

The acquisition of Diplomat's compounding pharmacy assets by Restore Health enables Diplomat to continue their singular focus on specialty pharmacy, the companies stated. 

September 10, 2015

A new report from the Pharmaceutical Research and Manufacturers of America is highlighting the large volume of cancer medicines and vaccines that are currently being developed, as well as the impact innovations have had on cancer death rates. 

September 10, 2015

Purdue Pharma this week announced that it had VM902A, acquired an allosteric selective tropmyosin receptor kinase A (TrkA) inhibitor, from VM Pharma.

September 3, 2015

 The drug, a biosimilar version of Amgen’s Neupogen, is the first biosimilar drug to launch in the U.S.

September 1, 2015

The company said the patch is a potential solution for the 73% of migraine sufferers who experience nausea with their migraines. 

August 25, 2015

Amneal Pharmaceuticals announced Tuesday that it would be opening a new biosciences unit, that will be focused on commercializing specialty pharmaceuticals. 

August 25, 2015

The drug can be used in children 1 year of age and older with ITP who have not had a sufficient response to a splenectomy, immunoglobulins or corticosteroids.

August 24, 2015

After years of research and billions of dollars in funding, the Human Genome Project has unlocked the complex mysteries of the human genome and unleashed a new era in personalized medicine and pharmaceutical research and development. And pharmacy retailers must get out in front of that gene-based drug revolution or risk being left behind.

August 21, 2015

Diplomat Pharmacy’s summer internship and fellowship program saw 10 fellows and 25 interns spend 12 weeks gaining hands-on experience in different departments of the specialty pharmacy. 

August 14, 2015

Keveyis is the first medicine approved by the FDA for the treatment of primary periodic paralysis, which is estimated to affect approximately 5,000 people in the United States.

August 14, 2015

The research project will provide pharmacogenomics services in community pharmacies including collection of DNA samples, interpretation of patient results, counseling and collaboration with prescribers. 

August 12, 2015

BioPlus is now one of over 70 founding and corporate members of NASP.

August 11, 2015

Iressa is a once-daily oral medication that targets and blocks the activity of epidermal growth factor receptor-tyrosine kinase.

August 7, 2015
The Well Beyond HIV mobile art exhibit in Chicago is traveling across the U.S. to help bring awareness of the many patients with HIV/AIDS who are living more than 20 years beyond original expectations.
August 6, 2015

The specialty pharmacy arm of Fred's Super Dollar today comprises 12% of the discount retailer's total sales. 

August 4, 2015

Armada Health Care on Tuesday announced a partnership with the clinical pharmacy services unit at the University of Massachusetts Medical School to work on its ArmadaOne specialty pharmacy platform. 

August 4, 2015

As much as $91 million of revenue from new drugs helped drive a 49% increase in sales and a 19% increase in prescriptions dispensed through Diplomat. 

July 24, 2015

Diplomat Pharmacy has partnered with Pharmaca Integrative Pharmacy to offer Pharmaca patients access to specialty pharmacy services.

July 15, 2015

The Food and Drug Administration is exploring extending PDUFA through 2022.